Pew Submits Comments to National Medical Device Postmarket Surveillance Planning Board

On April 27, The Pew Charitable Trusts submitted comments to the U.S. Food and Drug Administration on the National Medical Device Postmarket Surveillance Planning Board's report, Strengthening Patient Care: Building an Effective National Medical Device Surveillance System.

The Planning Board—composed of a broad range of medical device, industry, and regulatory experts, as well as representatives from the private sector and federal agencies—is working to build a robust tracking system that will ensure the safety and effectiveness of medical devices, such as artificial hips and cardiac stents.

Read Pew's full comments.